Home/Filings/4/0001628280-24-031204
4//SEC Filing

Schwaneke Jeffrey A. 4

Accession 0001628280-24-031204

CIK 0001831097other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 6:56 PM ET

Size

10.4 KB

Accession

0001628280-24-031204

Insider Transaction Report

Form 4
Period: 2024-07-01
Schwaneke Jeffrey A.
Chief Financial Officer
Transactions
  • Award

    Common Stock

    2024-07-01+377,074441,124 total
  • Award

    Common Stock

    2024-07-01+131,976573,100 total
  • Award

    Common Stock

    2024-07-01+150,830723,930 total
  • Award

    Options (Rights to Buy)

    2024-07-01+239,072239,072 total
    Exercise: $6.07Exp: 2034-07-01Common Stock (239,072 underlying)
Footnotes (5)
  • [F1]Restricted stock units that vest in three equal installments on each anniversary of July 1, 2024.
  • [F2]Includes restricted stock units.
  • [F3]Restricted stock units that vest in four equal installments on each anniversary of July 1, 2024.
  • [F4]Performance Stock Units may become vested subject to attainment (based on 40 trading day average closing price, exceeding twice the closing price of the Company's stock price on date of grant) and within three years from grant date.
  • [F5]Options that vest in four equal installments on each anniversary of July 1, 2024.

Issuer

agilon health, inc.

CIK 0001831097

Entity typeother

Related Parties

1
  • filerCIK 0001446919

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 6:56 PM ET
Size
10.4 KB